Portfolio Lab

Zoetis Inc.

  • Stock
  • Ticker ZTS
  • ISIN US98978V1035
  • NYSE

Health care · Pharmaceuticals · USA

$79.11 −2.08%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Zoetis Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ZTSGlobal equities (VT)

$10,000 grew to $17,351. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −70.4% in 10/2026, measured from the peak in 12/2021. The old peak has not been reached again yet.

1-year return
−30.2%
5-year return p.a.
−18.0%
10-year return p.a.
+5.7%
Volatility p.a.
25.0%
Largest decline
−70.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue2,3172,1982,4742,4222,3732,2622,4682,391
Gross profit1,6101,5801,8101,7251,6861,6211,7951,693
Net income581602726721624601691591
Earnings per share1.291.341.631.631.421.421.651.44
Balance sheet
Total assets14,23714,09814,47915,15915,49015,15415,07715,088
Liabilities9,4679,4439,5029,76112,07511,92111,92911,785
Equity4,7704,6554,9775,3983,4153,2333,1483,303
Cash1,9871,7211,4352,0842,4501,9411,4761,333
Long-term debt5,2205,2275,2317,0699,0429,0459,0488,299
Cash flow
Operating cash flow905515605936848401655824
Capital expenditure-216-178-146-138-159-110-117-107
Free cash flow689337459798689291538717

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2019 at +55.7%, weakest 2022 at −39.5%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$1.44
6 Aug 2026$1.65
7 May 2026$1.42
12 Feb 2026$1.42
4 Nov 2025$1.63
5 Aug 2025$1.63
6 May 2025$1.34
13 Feb 2025$1.29
4 Nov 2024$1.50
6 Aug 2024$1.37
2 May 2024$1.31
13 Feb 2024$1.14

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€29bn
Market cap in trading currency
$32.1bn
Enterprise value
$39.7bn
P/E
13.3
P/S
3.39
P/B
9.73
EV/Sales
4.18
EV/EBITDA
10.3
Earnings yield
7.5%
FCF yield
7.0%

Results (last four quarters)

Revenue
$9.49bn
Gross profit
$6.80bn
EBITDA
$3.86bn
Net income
$2.51bn
Earnings per share
$5.93
Revenue per share
$23.37
Revenue growth
−1.3%
Earnings growth
−18.0%

Profitability

Gross margin
71.6%
Operating margin
35.6%
Net margin
26.4%
Return on equity
57.6%
Return on assets
16.6%

Balance sheet and cash flow

Cash
$1.53bn
Cash per share
$3.77
Financial debt
$9.05bn
Debt/equity %
274
Current ratio
2.35
Book value per share
$8.13
Operating cash flow
$2.73bn
Free cash flow
$2.24bn

Dividend

Dividend yield
2.68%
Dividend (12 months)
$2.12
Yield (12 months)
2.68%
Payout ratio
36%
Ex-dividend date
30 Oct 2026

Shares and trading

Shares outstanding
406m
Volume
6.09m
Avg. volume 3 months
4.50m
Relative volume
1.4

Price and technicals

Price
$79.11
1 day
−2.1%
52-week high
$131.10
52-week low
$69.10
Distance to 52-week high
−39.7%
Distance to 52-week low
+14.5%
Distance to 50-day line
+2.5%
Distance to 200-day line
−12.5%
RSI (14)
46
Volatility 1M
53.3%

Performance

1 week
−5.6%
1 month
−3.5%
3 months
+2.5%
6 months
−2.7%
YTD
−37.1%
1 year
−32.4%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ZTS performed since 11/2016?

$10,000 grew to $17,351 by 20 Nov 2026, which is +5.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ZTS?

Volatility was 25.0% per year, measured on monthly returns. The largest decline from a peak was −70.4%, with the low in 10/2026.

How does ZTS compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ZTS returned +5.7% at 25.0%. The correlation of monthly returns was 0.42; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Zoetis Inc. (ZTS): Return and risk | Portfolio Lab